Renal function in surgical patients after administration of low-flow sevoflurane and amikacin

Hideyuki Higuchi1, Yushi Adachi

  • 1Department of Anesthesia, Self Defense Force Hanshin Hospital, 4-1-50 Kushiro, Kawanishi, Hyogo 666-0024, Japan.

Journal of Anesthesia
|October 21, 2003
PubMed
Abstract

Insights

This study found no increased kidney damage when amikacin was given with sevoflurane anesthesia. Combining an aminoglycoside antibiotic with sevoflurane did not worsen nephrotoxicity in surgical patients.

Area of Science:

  • Anesthesiology
  • Nephrology
  • Pharmacology

Background:

  • Compound A, a sevoflurane degradation product, is nephrotoxic in rats.
  • Aminoglycosides are known to cause nephrotoxic injury in humans.
  • Concurrent administration of nephrotoxins may potentiate renal damage.

Purpose of the Study:

  • To investigate the potential synergistic nephrotoxic effects of aminoglycosides in patients undergoing anesthesia with low-flow sevoflurane.
  • To assess the impact of amikacin on renal function markers during sevoflurane anesthesia.

Main Methods:

  • A comparative study involving 18 patients receiving amikacin and 19 control patients.
  • Both groups received sevoflurane anesthesia with low fresh gas flow (1 L/min) and cefotiam antibiotic.
  • Urinary excretion of biomarkers including total protein, albumin, beta(2)-microglobulin, glucose, and NAG was measured.
  • Amikacin was administered intravenously at 400 mg/day from anesthesia induction to day 2 post-anesthesia.

Main Results:

  • Anesthesia duration and mean Compound A concentrations were similar between the amikacin and control groups (P > 0.05).
  • Baseline renal function markers (blood urea nitrogen, serum creatinine) showed no significant differences between groups.
  • No significant differences were observed in the maximum or average urinary excretion of measured biochemical markers post-anesthesia.

Conclusions:

  • The co-administration of amikacin and sevoflurane did not result in a synergistic increase in nephrotoxicity in human surgical patients.
  • This study suggests that amikacin does not potentiate Compound A-induced nephrotoxicity under these clinical conditions.

Related Concept Videos

Stages of General Anesthesia01:22

Stages of General Anesthesia

Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Imaging Studies VII: Vascular Imaging01:19

Imaging Studies VII: Vascular Imaging

DefinitionRenal angiography, also known as renal arteriography, is an imaging technique used to obtain a comprehensive view of blood flow and the vascular structure of blood vessels in the kidneys and surrounding areas.PurposeRenal angiography detects blood vessel abnormalities in the kidneys, such as aneurysms, stenosis, thrombosis, vascular tumors, and renal artery stenosis. It evaluates kidney function and guides interventional treatments like angioplasty or stent placement.Pre-Procedure...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...